Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study
CKD was highly prevalent in people with T2D managed by endocrinologists. Despite the high presence of comorbidities and medication use, we observed an important lack of screening and proper CKD identification.
Authors
- José Ignacio Martínez‐Montoro (ORCID: https://orcid.org/0000-0001-9761-6888)
- José Carlos Fernández‐García (ORCID: https://orcid.org/0000-0003-2229-8488)
- José Juan Aparicio-Sánchez
- Belén Pimentel (ORCID: https://orcid.org/0000-0003-4194-9231)
- Mónica Juárez-Campo
- María Luisa Alamillo
Institutions
- Saint Louis University (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- AstraZeneca (Spain) (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1016/j.diabres.2025.112326
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- AstraZeneca
- AstraZeneca España
- Instituto de Salud Carlos III
- European Regional Development Fund